Charming Medical Limited (MCTA)

29.36 +0.00% (+0.00)

Over 6M: +0.0%

2026-08-28

29.2 29.4 29.6

Mar Apr May Jun Jul Aug

Financials Annual

Figures

Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›

0 2M 4M 6M 8M

FY24 FY25 FY26

Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-03-31, reported in USD. The newest fact in the filings is dated 2026-03-31, 152 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.2

SBC / sales 0.0%

Adj. EBITDA margin 3.9%

OE margin -32.4%

Oper. margin -0.61%

Gross margin 99.3%

Asset turnover 0.49×

Capex / sales 7.1%

Accruals 12.1%

EBITDA margin 3.9%

FCF margin -32.4%

OCF margin -25.3%

Profit margin -0.47%

ROA -0.23%

ROCE -0.53%

ROE -0.44%

OCF / EBIT —

ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5

Div. yield —

EV/EBIT —

EV/GP —

EV/OE —

EV/Sales —

FCF yield —

Fwd P/E —

P/B —

P/C —

P/E —

PEG —

Shareholder yield —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

7.2

RPO / sales 0.63×

Gross margin stability across years 0.24 pp

Cash-flow margin stability 14.7 pp

Prepaid revenue growth -12.0%

RPO growth —

Revenue growth in the worst year on record —

Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5

Current ratio 6.4×

ND/EBITDA —

Interest cover -1.9×

Cash / Debt 32.4×

Debt / Eq 0.036×

Debt payback 0.0 yr

Net debt / Eq 0.0×

Quick ratio 1.9×

Cash runway 3.8 yr

Equity / Assets 52.5%

F-score 1.1 pts

Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0

Most recent margin move -29.5

Operating margin trend -8.7

Sales/sh Y/Y -26.6%

Shares change +5.3%

EPS Y/Y -101.8%

Div. growth —

EBIT CAGR —

EBIT Y/Y —

EPS CAGR 4Y —

EPS next Y —

Gross profit Y/Y —

Sales CAGR 4Y —

Sales Q/Q —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.